Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × Thalidomide × Clear all

NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse